Financials

  • Market Capitalization 7.59 M
  • Employee 8
  • Founded 2011
  • CEO Paul Kang
  • Website www.exicuretx.com
  • Headquarter Delaware, United States
  • FIGI BBG00GTJCSB4
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-6.86
ratio cours/chiffre d'affaires
—

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
4730
APRE
Aprea Therapeutics, Inc. - Common Stock
0.61 USD+3.39%-4.69%-20.78%-59.60%7.68 M USD
4733
CURX
Curanex Pharmaceuticals Inc - Common Stock
4.88 USD-8.10%+1.88%+10.66%+674.60%7.65 M USD
4742
SNGX
Soligenix, Inc. - Common Stock
0.34 USD-2.86%-5.56%-8.11%-69.91%7.40 M USD
4744
INM
InMed Pharmaceuticals Inc. - Common Shares
1.34 USD-1.47%+0.75%+3.88%-37.09%7.36 M USD

Nouvelles